Phase Ib/II Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Conditions: Hepatocellular Carcinoma Interventions: Drug: Valemetostat; Drug: Atezolizumab; Drug: Bevacizumab Sponsors: University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials